Your browser doesn't support javascript.
loading
Diversity and Complexity of the Large Surface Protein Family in the Compacted Genomes of Multiple Pneumocystis Species.
Ma, Liang; Chen, Zehua; Huang, Da Wei; Cissé, Ousmane H; Rothenburger, Jamie L; Latinne, Alice; Bishop, Lisa; Blair, Robert; Brenchley, Jason M; Chabé, Magali; Deng, Xilong; Hirsch, Vanessa; Keesler, Rebekah; Kutty, Geetha; Liu, Yueqin; Margolis, Daniel; Morand, Serge; Pahar, Bapi; Peng, Li; Van Rompay, Koen K A; Song, Xiaohong; Song, Jun; Sukura, Antti; Thapar, Sabrina; Wang, Honghui; Weissenbacher-Lang, Christiane; Xu, Jie; Lee, Chao-Hung; Jardine, Claire; Lempicki, Richard A; Cushion, Melanie T; Cuomo, Christina A; Kovacs, Joseph A.
Afiliação
  • Ma L; Critical Care Medicine Department, NIH Clinical Center, National Institutes of Health, Bethesda, Maryland, USA liang.ma@nih.gov.
  • Chen Z; Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
  • Huang DW; Leidos BioMedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA.
  • Cissé OH; Critical Care Medicine Department, NIH Clinical Center, National Institutes of Health, Bethesda, Maryland, USA.
  • Rothenburger JL; Department of Pathobiology, Canadian Wildlife Health Cooperative, Ontario Veterinary College, University of Guelph, Ontario, Canada.
  • Latinne A; EcoHealth Alliance, New York, New York, USA.
  • Bishop L; Critical Care Medicine Department, NIH Clinical Center, National Institutes of Health, Bethesda, Maryland, USA.
  • Blair R; Tulane National Primate Research Center, Tulane University, New Orleans, Louisiana, USA.
  • Brenchley JM; Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
  • Chabé M; Université Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019-UMR 8204-CIIL-Centre d'Infection et d'Immunité de Lille, Lille, France.
  • Deng X; Critical Care Medicine Department, NIH Clinical Center, National Institutes of Health, Bethesda, Maryland, USA.
  • Hirsch V; Laboratory of Molecular Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
  • Keesler R; California National Primate Research Center, University of California, Davis, Davis, California, USA.
  • Kutty G; Critical Care Medicine Department, NIH Clinical Center, National Institutes of Health, Bethesda, Maryland, USA.
  • Liu Y; Critical Care Medicine Department, NIH Clinical Center, National Institutes of Health, Bethesda, Maryland, USA.
  • Margolis D; Critical Care Medicine Department, NIH Clinical Center, National Institutes of Health, Bethesda, Maryland, USA.
  • Morand S; Institut des Sciences de l'Evolution, Université de Montpellier 2, Montpellier, France.
  • Pahar B; Tulane National Primate Research Center, Tulane University, New Orleans, Louisiana, USA.
  • Peng L; Critical Care Medicine Department, NIH Clinical Center, National Institutes of Health, Bethesda, Maryland, USA.
  • Van Rompay KKA; California National Primate Research Center, University of California, Davis, Davis, California, USA.
  • Song X; Critical Care Medicine Department, NIH Clinical Center, National Institutes of Health, Bethesda, Maryland, USA.
  • Song J; Center for Advanced Models for Translational Sciences and Therapeutics, University of Michigan Medical Center, University of Michigan Medical School, Ann Arbor, Michigan, USA.
  • Sukura A; Department of Veterinary Pathology, Faculty of Veterinary Medicine, University of Helsinki, Helsinki, Finland.
  • Thapar S; Critical Care Medicine Department, NIH Clinical Center, National Institutes of Health, Bethesda, Maryland, USA.
  • Wang H; Critical Care Medicine Department, NIH Clinical Center, National Institutes of Health, Bethesda, Maryland, USA.
  • Weissenbacher-Lang C; Department of Pathobiology, Institute of Pathology, University of Veterinary Medicine Vienna, Vienna, Austria.
  • Xu J; Center for Advanced Models for Translational Sciences and Therapeutics, University of Michigan Medical Center, University of Michigan Medical School, Ann Arbor, Michigan, USA.
  • Lee CH; Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA.
  • Jardine C; Department of Pathobiology, Canadian Wildlife Health Cooperative, Ontario Veterinary College, University of Guelph, Ontario, Canada.
  • Lempicki RA; Leidos BioMedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA.
  • Cushion MT; Department of Internal Medicine, College of Medicine, University of Cincinnati, Cincinnati, Ohio, USA.
  • Cuomo CA; Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
  • Kovacs JA; Critical Care Medicine Department, NIH Clinical Center, National Institutes of Health, Bethesda, Maryland, USA.
mBio ; 11(2)2020 03 03.
Article em En | MEDLINE | ID: mdl-32127451
ABSTRACT
Pneumocystis, a major opportunistic pathogen in patients with a broad range of immunodeficiencies, contains abundant surface proteins encoded by a multicopy gene family, termed the major surface glycoprotein (Msg) gene superfamily. This superfamily has been identified in all Pneumocystis species characterized to date, highlighting its important role in Pneumocystis biology. In this report, through a comprehensive and in-depth characterization of 459 msg genes from 7 Pneumocystis species, we demonstrate, for the first time, the phylogeny and evolution of conserved domains in Msg proteins and provide a detailed description of the classification, unique characteristics, and phylogenetic relatedness of five Msg families. We further describe, for the first time, the relative expression levels of individual msg families in two rodent Pneumocystis species, the substantial variability of the msg repertoires in P. carinii from laboratory and wild rats, and the distinct features of the expression site for the classic msg genes in Pneumocystis from 8 mammalian host species. Our analysis suggests multiple functions for this superfamily rather than just conferring antigenic variation to allow immune evasion as previously believed. This study provides a rich source of information that lays the foundation for the continued experimental exploration of the functions of the Msg superfamily in Pneumocystis biology.IMPORTANCEPneumocystis continues to be a major cause of disease in humans with immunodeficiency, especially those with HIV/AIDS and organ transplants, and is being seen with increasing frequency worldwide in patients treated with immunodepleting monoclonal antibodies. Annual health care associated with Pneumocystis pneumonia costs ∼$475 million dollars in the United States alone. In addition to causing overt disease in immunodeficient individuals, Pneumocystis can cause subclinical infection or colonization in healthy individuals, which may play an important role in species preservation and disease transmission. Our work sheds new light on the diversity and complexity of the msg superfamily and strongly suggests that the versatility of this superfamily reflects multiple functions, including antigenic variation to allow immune evasion and optimal adaptation to host environmental conditions to promote efficient infection and transmission. These findings are essential to consider in developing new diagnostic and therapeutic strategies.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Filogenia / Pneumocystis / Variação Genética / Proteínas Fúngicas / Glicoproteínas de Membrana / Genoma Fúngico / Evolução Molecular Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Filogenia / Pneumocystis / Variação Genética / Proteínas Fúngicas / Glicoproteínas de Membrana / Genoma Fúngico / Evolução Molecular Idioma: En Ano de publicação: 2020 Tipo de documento: Article